34 Folgen

Discoveries in technology, medicine, and nutrition are emerging with accelerating speed and improving our health and quality of life. Brought to you by Lonza, “A View On” podcast is a series of short conversations with industry leaders. Join us to discuss new trends that are impacting scientific research, drug discovery and business.

The series of monthly conversations with pharma, biotech and nutrition leaders from across industry and academia covers a wide range of topics from 3D bioprinting to therapeutic cannabinoids. In under ten minutes, each podcast takes the audience on a rapid but deep dive into an exciting development that promises to profoundly change or even revolutionize healthcare.

A view on Lonza

    • Wissenschaft
    • 5.0 • 8 Bewertungen

Discoveries in technology, medicine, and nutrition are emerging with accelerating speed and improving our health and quality of life. Brought to you by Lonza, “A View On” podcast is a series of short conversations with industry leaders. Join us to discuss new trends that are impacting scientific research, drug discovery and business.

The series of monthly conversations with pharma, biotech and nutrition leaders from across industry and academia covers a wide range of topics from 3D bioprinting to therapeutic cannabinoids. In under ten minutes, each podcast takes the audience on a rapid but deep dive into an exciting development that promises to profoundly change or even revolutionize healthcare.

    EPISODE 10: Drug Bioavailability Enhancement

    EPISODE 10: Drug Bioavailability Enhancement

    Peer into the future of drug development with this episode of #AViewOn Drug Bioavailability Enhancement, exploring how PBPK modeling enhances drug bioavailability and paves the way for personalized medicine. Join experts Deanna Mudie and John DiBella in this discussion on making medications safer and more effective.

    • 30 Min.
    EPISODE 9: Capsules for Targeted Therapy Delivery

    EPISODE 9: Capsules for Targeted Therapy Delivery

    Dive into the world of targeted capsules with Vincent Jannin from Lonza and explore how these advanced drug delivery systems are transforming patient care and offering new horizons in medicine.

    • 26 Min.
    EPISODE 8: A View On Particle Identification

    EPISODE 8: A View On Particle Identification

    Embark on a microscopic journey into particle identification — the unsung hero of phar-maceutical safety — and uncover how this vital process shields us from unseen threats in every single medication we take.

    • 25 Min.
    Episode 7: Mid-season wrap-up

    Episode 7: Mid-season wrap-up

    In this summary episode, A View On host Martina Ribar Hestericova shares a secret and goes over a selection of the best ideas from season three so far.

    • 14 Min.
    Episode 6: A View On CAR-T Therapies

    Episode 6: A View On CAR-T Therapies

    Dive into the world of CAR-T cells, their therapeutic potential, and the future of cancer treatments.

    • 24 Min.
    Episode 5: A View On Highly-Potent APIs

    Episode 5: A View On Highly-Potent APIs

    Explore manufacturing highly potent compounds as two Lonza experts delve into their production process, trends, and prospects.

    • 20 Min.

Kundenrezensionen

5.0 von 5
8 Bewertungen

8 Bewertungen

tyesjbv2345 ,

Great topics!

Awesome topics selection, loved the cannabinoid and exosomes

do ksb ,

Interesting and insightful

Input from the experts directly at the source of information, i love learning about the novel therapies

tttadac ,

Great overview of current pharma trends!

Cool topics

Top‑Podcasts in Wissenschaft

Aha! Zehn Minuten Alltags-Wissen
WELT
Das Wissen | SWR
SWR
Kopf voran
Schweizer Radio und Fernsehen (SRF)
radioWissen
Bayerischer Rundfunk
ZEIT WISSEN. Woher weißt Du das?
ZEIT ONLINE
Wissenschaftsmagazin
Schweizer Radio und Fernsehen (SRF)

Das gefällt dir vielleicht auch

Biotech 2050 Podcast
Biotech 2050
Business Of Biotech
Matt Pillar
The Long Run with Luke Timmerman
Timmerman Report
The Readout Loud
STAT
Citeline Podcasts
Citeline
The Daily
The New York Times